Lucid Motors found itself in a tough bind this week, fending off bankruptcy rumors and watching its stock price plunge as a result. The company quickly denied the report, calling it “completely false” and pointing to its available free cash flow as evidence that it has enough runway to operate into next year.
Technology
New cancer tech sends chemo straight to tumors
NEWYou can now listen to Fox News articles!
Chemotherapy can save lives, but anyone who has watched a loved one go through it knows how hard it can be. The nausea. The exhaustion. The infections. The days when even getting off the couch feels like too much.
That happens because standard chemotherapy travels through the bloodstream. It attacks cancer cells but can also harm healthy cells along the way. For some pancreatic cancer patients, that approach may be changing.
A targeted drug-delivery system from RenovoRx is designed to send chemotherapy directly near the tumor instead of through the entire body. The system, called Trans-Arterial Micro-Perfusion, or TAMP, is being studied in a Phase III clinical trial for locally advanced pancreatic cancer.
For 83-year-old Hernando Salcedo, who had been left weak, nauseous and overwhelmed by standard chemotherapy, the trial offered something he desperately needed: a reason to hope. He enrolled at Miami Cancer Institute and soon began to feel the shift in his own body. His appetite started coming back. His energy improved. He felt more like himself. “The difference was tremendous,” Hernando said. “I completed eight sessions, one every 15 days, and I felt dramatically better than I did with the original chemotherapy.”
HIDDEN FACTOR IN CANCER TREATMENT TIMING MAY AFFECT SURVIVAL, RESEARCHERS SAY
Cancer patient Hernando Salcedo attended a family wedding after RenovoRx’s Trans-Arterial Micro-Perfusion system delivered chemotherapy directly near his tumor, helping him feel stronger during treatment. (Hernando Salcedo)
Sign up for my FREE CyberGuy Report
- Get my best tech tips, urgent security alerts and exclusive deals delivered straight to your inbox.
- For simple, real-world ways to spot scams early and stay protected, visit CyberGuy.com – trusted by millions who watch CyberGuy on TV daily.
- Plus, you’ll get instant access to my Ultimate Scam Survival Guide free when you join.
How the RenovoRx drug-delivery device works
RenovoRx’s platform uses the FDA-cleared RenovoCath device to deliver chemotherapy through a catheter placed in an artery near the tumor. A physician guides the catheter into position using X-ray imaging.
Shaun Bagai, CEO of RenovoRx, said the platform is designed to localize chemotherapy delivery near the tumor instead of relying on the drug to travel through the whole body.
“Once in position, two small balloons on the catheter are inflated, and the system is adjusted to isolate a targeted segment of artery adjacent to a tumor,” Bagai said. “The chemotherapy drug is then infused between the balloons, creating pressure to push the drug across the vessel wall and near the tumor, directly bathing the target tumor.”
That setup allows doctors to focus treatment in a specific area rather than exposing more of the body to chemotherapy. “The procedure itself is minimally invasive and is typically performed in an outpatient setting without the need for patients to be put under general anesthesia,” Bagai said.
For patients already dealing with pain, fatigue and fear, that outpatient approach may feel less overwhelming than a major hospital procedure.
How targeted chemotherapy for pancreatic cancer works
To understand why this approach matters, it helps to start with the problem doctors are trying to solve. Dr. Ripal Gandhi, a vascular interventional radiologist and interventional oncologist at Baptist Health Miami Cardiac & Vascular Institute and Miami Cancer Institute, explained why standard chemotherapy can be so hard on the body.
“With IV chemotherapy, the drug travels through the bloodstream, affecting both cancerous and healthy cells, which can lead to side effects,” Dr. Gandhi said. TAMP takes a more targeted route. A doctor places a catheter in an artery near the tumor, then delivers chemotherapy into that area instead of relying on the drug to circulate throughout the body.
Dr. Gandhi compared it to “a drip irrigation system for individual plants instead of watering an entire lawn.” For patients, that means doctors are trying to focus more of the treatment near the cancer while reducing how much chemotherapy reaches the rest of the body.
Why pancreatic cancer is so difficult to treat
Pancreatic cancer has a reputation for being one of the hardest cancers to fight, partly because the tumor itself can block treatment from working the way doctors want it to.
Dr. Gandhi said that creates a major challenge for standard IV chemotherapy. “Studies have shown that less than 10% of chemotherapy administered intravenously actually reaches tumor cells due to the few blood vessels in the tumor as well as dense fibrous stroma, which serves as a physical barrier in the tumor microenvironment,” Dr. Gandhi said.
That helps explain why targeted delivery could play an important role. TAMP sends the drug closer to the tumor rather than depending on the bloodstream to do all the work.
“This targeted approach via TAMP does not rely on chemotherapy circulating through the body to carry the drug to the tumor via tumor feeder vessels,” Dr. Gandhi said. “Trans-arterial micro-perfusion is a drug-delivery platform that delivers chemotherapy directly near the target tumor where it is needed most.”
NEW CANCER THERAPY HUNTS AND DESTROYS DEADLY TUMORS IN MAJOR BREAKTHROUGH STUDY
Chase McCann, associate director of the cell therapy lab core, demonstrates how cancerous T-cells from a child are used to develop an autoimmune treatment to fight cancer at Children’s National Hospital in Washington, D.C., on Aug. 26, 2025. (Marvin Joseph/The Washington Post/Getty Images)
Patient says targeted chemotherapy gave him hope
Hernando’s cancer journey began after he went to the doctor with a swollen stomach and hip pain. Doctors diagnosed him with locally advanced pancreatic cancer. When he started standard chemotherapy in August 2025, the side effects hit hard. “My body was going through an incredible amount of stress,” Hernando said. “My stomach was inflamed, I had persistent pain in my head, and I had almost no energy.”
He was also receiving chemotherapy and radiation at the same time. “It was a very difficult period, both physically and emotionally,” he said. “I remember feeling exhausted, overwhelmed and unsure of what the future would look like.”
When doctors presented the targeted treatment option, Hernando saw it as more than another medical procedure. “To me, it felt like a new opportunity to live,” he said. “It gave me hope at a time when my family and I really needed it.”
He credits Dr. Gandhi and the team at Miami Cancer Institute with helping him through it all. “From the beginning, he was honest, supportive and clear with my wife, my family and me,” Hernando said. “That meant everything.”
Fewer chemotherapy side effects changed daily life
“Before, I was losing weight, had no appetite and felt drained,” Hernando said. “After switching treatments, things began to change. I stopped losing weight, my appetite came back, my color improved and I had more energy.”
Cancer treatment can sometimes take over everyday life. When side effects ease, patients can get pieces of their normal life back. “After about eight weeks, we could see real progress,” Hernando said. “I was eating more, moving more and feeling excited about life again.”
One moment still stands out. Hernando was able to attend a family wedding and dance the entire night. “That moment meant everything to me,” he said. “After everything I had been through, being able to celebrate with my family in that way felt like a gift.” For Hernando, it was a chance to feel like himself again. “That night at the wedding, I was not thinking only about cancer or treatment,” Hernando said. “I was living.”
Early trial results show survival and quality-of-life signals
The early data from RenovoRx’s Phase III TIGeR-PaC trial suggest the targeted approach may offer both survival and tolerability benefits for some patients.
Dr. Gandhi said completed clinical studies with TAMP in pancreatic cancer showed “a potential for better outcomes and less side effects for patients.”
“In the initial interim analysis of the TIGeR-PaC clinical trial, there was a trend towards improved overall survival by 6 months and improvement in the progression free survival by 8.1 months with 65% fewer adverse events in the TAMP arm of the study,” Dr. Gandhi said.
Who may benefit from targeted chemotherapy delivery?
This approach isn’t for every pancreatic cancer patient. Doctors still need to look at the cancer stage, tumor location, treatment history and whether the cancer has spread.
Dr. Gandhi said Hernando was the kind of patient who could be a strong fit. “He is precisely the type of patient who would benefit best from this approach because he has a tumor which is too far advanced to be treated surgically, but it has not spread to other organs,” Dr. Gandhi said.
He also pointed to clinical trials as an important option for pancreatic cancer patients.”I discussed with him that the recommendation of the National Comprehensive Cancer Network is that the best management for pancreatic cancer patients is participation in a clinical trial whenever possible and he was an ideal candidate,” Dr. Gandhi said.
He went on to say that TAMP may be an option for patients who are not candidates for surgery, patients who have failed chemotherapy or patients who no longer want to continue IV chemotherapy because of side effects.
“TAMP can be used at any point within the treatment landscape, before, during or after other treatment modalities such as IV chemotherapy or radiation,” he said.
PANCREATIC CANCER PATIENT SURVIVAL DOUBLED WITH HIGH DOSE OF COMMON VITAMIN, STUDY FINDS
The RenovoCath device uses a catheter-based system to deliver chemotherapy near the tumor instead of through the whole body. (RenovoRx)
What comes next for RenovoRx’s cancer treatment platform
RenovoRx says the RenovoCath catheter is already FDA-cleared for general therapy and chemotherapy delivery. The company is also nearing the end of enrollment in its Phase III TIGeR-PaC trial.
That trial is evaluating intra-arterial gemcitabine (IAG) delivered through RenovoCath for locally advanced pancreatic cancer. Bagai said enrollment is expected to be completed in mid-2026, with final results expected in 2027.
“If positive, data generated from this trial could potentially support a new drug application for this combination product to the FDA for IAG,” Bagai said. RenovoRx also sees potential beyond pancreatic cancer. “The challenge we are addressing is not unique to pancreatic cancer,” Bagai said.
He said the platform could apply to other solid tumors with limited blood supply, including bile duct cancer, certain lung cancers and sarcomas. “The platform is designed to work with different types of therapies, not just one drug,” Bagai said. “That opens the door to future combinations and potential partnerships, with the goal of expanding options for patients who have limited treatment choices.”
What this means to you
If you or someone you love has pancreatic cancer, this story is worth paying attention to. Clinical trials can open up options when standard treatment feels too hard to tolerate or stops working.
Drug delivery matters, too. The medicine itself is only part of the story. Where it goes inside the body can affect side effects, energy levels and quality of life. Targeted chemotherapy delivery remains a specialized treatment approach. Some cancer centers may not offer it, and every diagnosis will not be a fit. Your care team can review imaging, staging, prior treatments and overall health to see whether it makes sense.
Start with direct questions. Ask whether a clinical trial makes sense. You can also ask about targeted delivery options or a second opinion from a pancreatic cancer specialist. Hernando’s advice to other patients is simple. “I would tell them not to lose hope and not to wait to ask questions,” he said.
Take my quiz: How safe is your online security?
Think your devices and data are truly protected? Take this quick quiz to see where your digital habits stand. From passwords to Wi-Fi settings, you’ll get a personalized breakdown of what you’re doing right and what needs improvement. Take my Quiz here: Cyberguy.com
Kurt’s key takeaways
Pancreatic cancer has a way of turning normal life upside down fast. One day, a family is making plans. The next, they are trying to understand scans, treatment choices and side effects that no one feels ready for. That is what makes Hernando’s story so powerful. The part that stays with you isn’t only the technology. It is the fact that he started eating again. He had more energy. He felt more like himself. And he got to dance at a wedding after wondering what the future would look like. The final Phase III trial results will be important. Doctors still need to see how widely this approach could help patients. But the promise is easy to understand. If chemotherapy can get closer to the tumor while taking less of a toll on the rest of the body, patients may get something that matters just as much as treatment itself: more good days.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
If you or someone you loved needed chemo, would targeted delivery change how you think about treatment? Let us know by writing to us at Cyberguy.com
Sign up for my FREE CyberGuy Report
- Get my best tech tips, urgent security alerts and exclusive deals delivered straight to your inbox.
- For simple, real-world ways to spot scams early and stay protected, visit CyberGuy.com – trusted by millions who watch CyberGuy on TV daily.
- Plus, you’ll get instant access to my Ultimate Scam Survival Guide free when you join.
Copyright 2026 CyberGuy.com. All rights reserved.
But despite the swift response, the damage was widespread. The panic immediately bled into competing automakers, pulling down shares of Rivian and Polestar as investors speculated about the long-term survival of EV-only companies in the face of slowing consumer demand and whiplash policy shifts. And it cast a harsh light on the precarity of all three companies and the future of electric vehicles.
The trouble started on Tuesday, when EV trade publication EV reported that restructuring firm AlixPartners had advised Lucid’s board to consider Chapter 11 bankruptcy or a take-private deal. The report also said AlixPartners had encouraged the board to further restructure in the US and Europe and to focus on the Gravity SUV. But while the rest of the media has since reported on Lucid’s denial, no other publication has confirmed EV’s scoop. (For what its worth, EV’s URL is “eletric-vehicle.com,” enshrining the incorrect spelling in its address.)
Lucid confirmed that it had hired AlixPartners, but denied that the firm had made any such recommendations to its board. Instead, AlixPartners would provide advice on “improving execution, strengthening operations and positioning Lucid to realize the full potential of its technology, products and innovation,” Lucid chief communications officer Nick Twork said.
Lucid went a step further, filing a cease and desist order against EV
Lucid went a step further, filing a cease and desist order against EV, claiming that the site’s report directly led to the stock crash. “In short, your actions caused serious injury to a number of investors,” Lucid’s chief legal officer and general counsel, Brian Tomkiel, said in the letter. “And they injured, and continue to injure, Lucid directly.”
Still, the timing was terrible. Lucid is genuinely not in good shape, having lost over $1 billion in the first quarter of the year. The company has also gone through two rounds of layoffs in 2026, having cut 12 percent of staff in February and then 18 percent in June. The company also reduced production at its factory in Arizona in a bid to counteract its high inventory and save money. And there’s been leadership turmoil, with COO Marc Winterhoff departing the company and his position being eliminated entirely in an effort to flatten the structure.
The report sent the stock into freefall, plummeting as much as 50 percent in one of the worst single-day drops in Lucid’s history. And with Polestar and Rivian also catching strays, it’s generally been a glum time for companies not named Tesla trying make a go of exclusively building electric vehicles. Wall Street is panicking because the rumors are aligning with the bad news coming out of these companies’ earnings reports. EV sales are stabilizing, but recovery is still a distant promise. The all-electric future seems further away than ever.
Whether or not Lucid is actually weighing Chapter 11, it’s a sure sign of more turbulent waters ahead. Polestar getting strong-armed out of the US over its Chinese ties has left a lot of EV owners and dealers scratching their heads. Rivian is in an increasingly precarious position thanks to its huge, expensive bet on becoming a mass-market car company with the production of the R2.
All of these companies are increasingly reliant on big stakeholders — Lucid with Saudi Arabia’s Public Investment Fund, Polestar with Geely, and Rivian with Volkswagen — for their future survival. If any of these big backers get cold feet, the future could get really dark really fast.
Follow topics and authors from this story to see more like this in your personalized homepage feed and to receive email updates.
NEWYou can now listen to Fox News articles!
AssuranceAmerica, an auto insurance provider that works through a network of independent agents, has disclosed a data breach affecting nearly 7 million people. The exposed information includes driver’s license numbers and other personal details tied to auto insurance customers.
The company said it detected suspicious activity on March 17, 2026, after malicious activity targeted one of its employees one day earlier. Investigators later found that an unauthorized third party accessed parts of AssuranceAmerica’s IT environment and copied certain data files.
According to an Indiana Attorney General breach listing, the incident affected 6,998,886 people. A California Attorney General notice also says AssuranceAmerica began notifying affected individuals after completing its file review on June 15, 2026.
AssuranceAmerica sells auto, renters and commercial auto insurance through independent agents. So even if the company name does not sound familiar, your information could still be involved if your policy, quote, claim or driver details passed through its systems.
ADT DATA BREACH EXPOSES CUSTOMER INFORMATION
AssuranceAmerica says a March cyberattack exposed personal information tied to nearly 7 million people, including driver’s license numbers and insurance data. (Felix Zahn/Photothek via Getty Images)
Free live CyberGuy class: Sick of Spam? Join us July 22
Join us Wednesday, July 22, at 1 p.m. ET for a free CyberGuy Live class that will help you cut down on robocalls, spam texts, junk email and other unwanted messages. Kurt “CyberGuy” Knutsson will walk you step by step through simple ways to filter spam, clean up your inbox and recognize the messages that could put your personal information at risk. No technical experience is needed. You’ll also receive our spam-stopping checklist, and every registrant will get a link to the class recording afterward.
Reserve your free spot today at CyberGuyLive.com.
What happened in the AssuranceAmerica data breach
AssuranceAmerica said the breach started with malicious activity that targeted one employee. The company did not explain exactly how the employee was targeted. However, it said it later disabled compromised credentials and unauthorized sessions.
That detail should get your attention. Many breaches start with one stolen login, one convincing message or one infected device. Once attackers get inside, they can move quickly and look for files worth stealing.
In this case, AssuranceAmerica said an unauthorized third party copied certain data files from its IT environment. The company then reviewed those files to identify affected individuals.
What information was exposed in the AssuranceAmerica breach
AssuranceAmerica said the stolen files contained names plus one or more other types of personal information. That information may include contact details, auto insurance policy or account information, driver or vehicle information, claims-related information and driver’s license numbers. The California notice also says some files may have included Tax ID information and/or Social Security numbers.
That mix can create real risk. A scammer with your name, license number and insurance details may sound much more convincing. They could pretend to be from your insurer, a repair shop, a claims department or a state agency. This follows other identity-document breaches, including the Texas data breach that hit 3 million license customers. Once driver’s license numbers leak, the risk can last much longer than a stolen credit card number.
How AssuranceAmerica responded to the breach
AssuranceAmerica said it took affected server devices offline and hired external forensic specialists to investigate. The company also said it reset passwords, deployed enhanced monitoring and threat detection tools and gave employees more cybersecurity instruction. It also notified law enforcement.
AssuranceAmerica is offering 12 months of complimentary credit monitoring for affected individuals. That can help spot some suspicious activity. However, you still need to watch your insurance account, financial accounts and mail.
Why the AssuranceAmerica breach puts drivers at risk
A driver’s license number can help an imposter build a more believable scam. Insurance information can make that scam feel personal.
For example, a caller may mention your policy, your vehicle or a claim. Then they may ask you to “verify” more information. That is where the damage can grow.
Also, stolen breach data can be matched with public records and data broker profiles. That can give criminals a fuller picture of your life. We have seen the same pattern in scams tied to travel accounts, phone accounts and other breaches, including the Booking.com breach that exposed traveler data to scams.
BEFORE YOU CONNECT ANOTHER SMART TV, TABLET OR PHONE, LOCK IT DOWN
State officials say the breach involved Medicaid, Medicare Savings Program and rehabilitation services records spanning multiple years. (Photo by Silas Stein/picture alliance via Getty Images)
Ways to stay safe after the AssuranceAmerica data breach
If you receive a notice or think your information may be involved, take these steps now to make the stolen data harder to use.
1) Read the breach notice closely
If you receive a notice from AssuranceAmerica, read it carefully. Check what information the company says may have been exposed in your case. Do not assume every affected person had the same data stolen. Some people may have had driver’s license numbers exposed. Others may also have had Tax ID information or Social Security numbers involved.
2) Use the credit monitoring offer safely
AssuranceAmerica says it is offering 12 months of complimentary credit monitoring. Use the instructions in the official notice. Be careful with emails or texts that claim to offer enrollment links. Scammers often copy real breach language to trick you.
3) Freeze your credit
A credit freeze makes it harder for someone to open a new account in your name. You need to place a freeze separately with Equifax, Experian and TransUnion. It is free, and you can lift it when you need to apply for credit.
4) Add a fraud alert
A fraud alert tells lenders to take extra steps before opening credit in your name. You can place a fraud alert with one credit bureau, and that bureau should notify the others. This adds another layer of protection if your personal information was exposed.
5) Watch your insurance account
Log in to your insurance account and check for changes you do not recognize. Look for unfamiliar claims, new contact details or strange policy updates. If something looks wrong, call the company using a number from your policy documents.
6) Protect your devices from malware
Credential theft often starts with malware, a bad link or a fake download. Strong antivirus software can help block malicious files and phishing links before they cause damage. Get my picks for the best 2026 antivirus protection winners for your Windows, Mac, Android & iOS devices at Cyberguy.com
CARNIVAL BREACH MAY PUT YOUR TRAVEL DATA AT RISK
Strong passwords protect your accounts, but they do not stop data brokers from collecting public records and selling personal information to people-search sites. (Photographer: Chris Ratcliffe/Bloomberg via Getty Images)
7) Clean up your online personal data
Breached data becomes more useful when scammers can match it with your address, relatives, phone number or public records. A data removal service can help reduce what data brokers display about you. That will not undo a breach, but it can make you a harder target. Check out my top picks for data removal services and get a free scan to find out if your personal information is already out on the web by visiting CyberGuy.com.
8) Be suspicious of insurance-related calls
If someone calls about your policy, claim or payment, slow down. Do not share verification codes. Do not confirm sensitive details during an unexpected call. Instead, hang up and call the company back through an official number.
9) Check your DMV options
If your driver’s license number was exposed, review your state DMV’s fraud guidance. Some states may offer replacement options or identity theft guidance. The rules vary, so check directly with your state agency.
10) Use a password manager
Create strong, unique passwords for your insurance account, email and financial apps. A password manager can also help you spot fake login pages. If it will not autofill, you may be on a scam site. Check out the best expert-reviewed password managers of 2026 at CyberGuy.com.
11) Turn on two-factor authentication
Turn on two-factor authentication (2FA) for your insurance account, email and financial accounts when available. Use an authenticator app when you can. Text codes are better than nothing, but scammers often target them.
Kurt’s key takeaways
The AssuranceAmerica data breach is a reminder that your driver’s license number has become a high-value target. You may not be able to control how every company stores your information. However, you can make stolen data harder to use. Start with your credit. Then check your insurance account and watch for imposters who know just enough to sound convincing. Also, clean up the personal data already floating around online. The bigger issue is trust. Companies ask for sensitive information because they need it to do business. When that information leaks, you are the one left checking statements, freezing credit and worrying about what comes next.
What should a company owe you when it loses the ID number you use to prove who you are? Let us know by writing to us at CyberGuy.com.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
Sign up for my FREE CyberGuy Report
- Get my best tech tips, urgent security alerts and exclusive deals delivered straight to your inbox.
- For simple, real-world ways to spot scams early and stay protected, visit CyberGuy.com – trusted by millions who watch CyberGuy on TV daily.
- Plus, you’ll get instant access to my Ultimate Scam Survival Guide free when you join.
Copyright 2026 CyberGuy.com. All rights reserved.
Epic Games and Google have just jointly withdrawn their attempt to retroactively settle the lawsuit that’s changing how Android app stores work in the United States — and that means Google will be forced to carry rival app stores inside of its own. In fact, Google tells the court, it’s ready to begin carrying third-party app stores on Wednesday, July 22nd. Does that mean it’s time for Microsoft to launch an Xbox game store on Android?
But Judge James Donato was skeptical he should abandon his original permanent injunction in favor of Google’s proposed “Registered App Stores” that users would have to sideload — instead of simply downloading third-party stores directly through Google Play. On Thursday, July 16th, both parties were set to appear in court to argue it again, but that may no longer be necessary.
Here’s is Google’s full statement on withdrawing its proposed modifications to Judge Donato’s permanent injunction, via Google spokesperson Dan Jackson:
We’ve agreed with Epic to withdraw our motion to modify the US Court’s injunction rather than prolonging this process which creates uncertainty for the ecosystem. This allows us to focus on executing our recently announced global business model evolution to deliver greater app store choice, lower prices, and more opportunities for developers and users. We remain committed to maintaining Android’s industry-leading security and fostering a competitive ecosystem where every app store and developer has the freedom to compete. In parallel, we continue to comply with the US Court’s injunction.”
Google had previously announced that it would launch its sideloaded Registered App Store program in the rest of the world, beginning with the new version of Android later this year. That means there may be two different tracks for Android: stores-within-a-store in the United States, and Registered App Stores everywhere else.
It’s not yet clear if there will be a parallel “program” for third-party app stores inside of the Google Play Store, or if companies will simply submit them the way they’d submit any other app. Technically, the court’s permanent injunction states that Google “may not prohibit the distribution of third-party Android app distribution platforms or stores through the Google Play Store,” not that it has to proactively invite them in.
For access to the Google Play catalog of apps, Google will charge stores an annual fee of $5,000 for “security and policy reviews,” and it has many additional requirements, including: stores can’t distribute apps outside of the US, have to be open to all eligible third-party developers, have “clear, non-discriminatory” trust and safety policies, and no more than 1 percent of “install attempts” can be malware.
-
Entertainment5 minutes ago‘You’re scaring my people.’ Shia LaBeouf’s alleged stalker arrested after posting viral video
-
Politics17 minutes agoCalifornians back Becerra and reject AI data centers by big margins, poll finds
-
Science23 minutes agoHow to eat safely amid outbreak of diarrhea-causing cyclosporiasis
-
Sports29 minutes agoMagical Lionel Messi leads Argentina past England for trip back to World Cup final
-
World41 minutes agoToronto engulfed by wildfire smoke as US cities threatened
-
News1 hour agoArgentina is back in the World Cup final after a thrilling semifinal win over England
-
Los Angeles, Ca3 hours agoRemains of murder victim identified as missing Southern California millionaire
-
Detroit, MI3 hours ago4Warn Weather Alert: Wildfire smoke leading to ‘unhealthy’ air quality in Metro Detroit
